Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learning.

Dogra S, Kouznetsova VL, Tsigelny IF

Open source

DOI
10.1080/21678421.2025.2536027
Published
2026 Feb
Container
Amyotrophic lateral sclerosis & frontotemporal degeneration
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21678421.2025.2536027,
  title = {Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learning.},
  author = {Dogra S and Kouznetsova VL and Tsigelny IF},
  year = {2026},
  journal = {Amyotrophic lateral sclerosis \& frontotemporal degeneration},
  doi = {10.1080/21678421.2025.2536027},
  url = {https://doi.org/10.1080/21678421.2025.2536027}
}

RIS

TY  - JOUR
TI  - Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learning.
AU  - Dogra S
AU  - Kouznetsova VL
AU  - Tsigelny IF
PY  - 2026
JO  - Amyotrophic lateral sclerosis & frontotemporal degeneration
DO  - 10.1080/21678421.2025.2536027
UR  - https://doi.org/10.1080/21678421.2025.2536027
ER  - 

APA

S, D., VL, K., & IF, T. (2026). Repurposing FDA-approved drugs for treatment of amyotrophic lateral sclerosis using machine learning.. Amyotrophic lateral sclerosis & frontotemporal degeneration. https://doi.org/10.1080/21678421.2025.2536027

Source records